Clinical trial
A Phase 2, Open-label Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
NCT03831607 is registered in ClinicalTrials.gov with Kyowa Kirin Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open-label Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Lead sponsor
- Kyowa Kirin Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 27, 2018
- Completion date
- November 26, 2019
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.